No applicable
Conditions
Interventions
Smell the scent of 3 kinds of black tea (A,B,C) in order A, B and C.
Smell the scent of 3 kinds of black tea (A,B,C) in order B, C and A.
Smell the scent of 3 kinds of black tea (A,B,C) in order C, A
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Females aged 20 to 39 years old. (2) Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent.
Exclusion criteria
Exclusion criteria: (1)Subjects who dislike the scent of black tea. (2) Subjects who have smoking habit. (3) Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) (4) During the past month, subjects who have been received medication for the treatment of diseases. (5) During the past month, subjects who have been received treatment of pollen allergy. (6) Subjects who have stuffy nose from allergic rhinitis or who can't distinguish scent. (7) Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. (8) Subjects with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. (9) Pregnant or expected pregnant, or lactating women. (10) Subjects who have symptom of dermatologic disease such as atopic dermatitis. (11) Subjects who have undergone surgery on investigation objective portion within the past 6 months. (12) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study. (13) Subjects who themselves and/or their family are working for a company that develops, manufactures or sells health / functional foods and cosmetics. (14) Others who have been determined ineligible by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of autonomic nervous system | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS questionnaire Preference questionnaire | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Planning & Sales Department
Outcome results
None listed